Description:

Z1031: Adverse Events Form Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FAD7AE3C-C9A3-1CD3-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FAD7AE3C-C9A3-1CD3-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00265759 Toxicity - Z1031: Adverse Events Form - 2316417v3.0

No Instruction available.

  1. StudyEvent: Z1031: Adverse Events Form
    1. No Instruction available.
Header Module
Visit
Instructions
Was patient hospitalized during this reporting interval
Has an Adverse Event Expedited (AdEERS) Report been submitted
Ae Module
Common Toxicity Criteria Adverse Event Term Type
CTC AE Attribution Code (see above)
Header
Other Ae Module
CTC AE Attribution Code (see above)

Similar models